ri:val for Business Development and Licensing
Make optimal decisions
Understand the value and the risk of licensing opportunities, e.g., how likely
are my cash flows with the current distribution of royalties vs. milestones?
Compare the licensing opportunities with internal projects or previously closed deals, e.g., what were the value share and return on investment of your previous phase 1 license deals?
Assess the financial attractiveness of license deals, e.g., what is the ROI of a possible deal, and is it higher than an alternative?
Structure, value, and adapt possible license deals
Easily value and analyze sophisticated deal structures, e.g., co-development,
co-marketing, multiple geographical markets, or tiered royalties.
Adapt the risk structure of the contract to your needs, e.g., what
happens to the value and risk of your contract when cutting the royalty
rate down to 8% for sales under US $200 million?
Negotiate better deal terms
Know the value and expected return of a term sheet and compare it to
closed deals, e.g., your last preclinical deal was a 20%–80%
share; what share do you reach with the current deal terms?
See what the deal means to your counterparts and find out the worth of both sides of the contract structure before your negotiations.
Find the right deal terms, e.g., what terms should you propose to come to a value share of 40%–60%?
ri:val is your key to creating sustainable value in licensing.
What's Next
To take advantage of ri:val software or to learn how ri:val can benefit you, contact us by phone or email us at info@avance.ch
![]()
Find out about having a personal or online demo.
![]()
![]()
Get on the ri:val mailing list and sign up for our email newsletter to discover what's new about ri:val and topical industry information.